Compare RYAM & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RYAM | BVS |
|---|---|---|
| Founded | 1926 | 2011 |
| Country | United States | United States |
| Employees | 2325 | N/A |
| Industry | Paper | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 751.8M | 617.1M |
| IPO Year | 2014 | 2016 |
| Metric | RYAM | BVS |
|---|---|---|
| Price | $10.81 | $9.18 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $14.00 | $14.00 |
| AVG Volume (30 Days) | ★ 1.4M | 379.0K |
| Earning Date | 03-03-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | N/A | ★ 0.33 |
| Revenue | ★ $1,466,397,000.00 | $568,087,000.00 |
| Revenue This Year | N/A | $7.43 |
| Revenue Next Year | $8.22 | $6.61 |
| P/E Ratio | ★ N/A | $27.76 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.35 | $5.81 |
| 52 Week High | $11.85 | $9.56 |
| Indicator | RYAM | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 56.85 | 60.47 |
| Support Level | $6.91 | $7.04 |
| Resistance Level | $11.85 | $9.53 |
| Average True Range (ATR) | 0.46 | 0.31 |
| MACD | -0.11 | 0.02 |
| Stochastic Oscillator | 51.72 | 90.04 |
Rayonier Advanced Materials Inc engaged in the production and sale of high-purity cellulose and other cellulose-based materials derived from renewable wood fiber. The company operates through five segments: Cellulose Specialties, which produces highly purified cellulose used in products such as filters, pharmaceuticals, food additives and electronics; Biomaterials, which produces products including biofuels, lignosulfonates and other bio-based chemicals; Cellulose Commodities, which manufactures absorbent and viscose pulp used in textiles and hygiene products; Paperboard, which produces coated paperboard used for packaging and printing applications; and High-Yield Pulp, which produces pulp used in paperboard, packaging and printing paper products.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.